Core Insights - The forum on "Medical Device Technology Review and High-Quality Development" highlighted the rapid growth and innovation in Beijing's medical device industry, with a projected revenue exceeding 1 trillion yuan in 2024 [1][3] Industry Overview - Beijing has established itself as a national innovation hub for the medical device sector, with over 81 approved Class III innovative medical devices, accounting for more than 20% of the national total [3][4] - The city leads the nation in the number of artificial intelligence medical products (58) and surgical robots (34) [3][4] - The medical device industry in Beijing is projected to generate an industrial output value of 48 billion yuan and a market operation and trade value of 186.3 billion yuan in 2024 [3] Regulatory Environment - The Beijing Drug Administration has implemented measures to streamline the review and approval process for medical devices, reducing the average review time for the first registration of Class II medical devices to 43 working days [3][5] - A comprehensive medical device testing base has been established, with 1,661 authorized testing capabilities [3][5] Regional Development - Yizhuang, a key area for the development of Beijing's medical and health industry, houses over 5,000 medical health enterprises and is expected to exceed 16 billion yuan in medical device output by 2025 [4] - Yizhuang has entered the special review process for 56 innovative medical devices, with 25 approved for market entry [4] Expert Involvement - The National Medical Products Administration's Medical Device Technical Review Center has over 2,500 experts, including 41 academicians, across 136 professional fields to support the review process [5][6] - The establishment of a collaborative platform for innovative biomaterials aims to address critical issues in the field and enhance national strategic security [6] Market Trends - Domestic products account for two-thirds of the corneal reshaping lens market in China, with 19 domestic products and 11 imported products approved [7] - The clinical evaluation of artificial intelligence medical devices is crucial, focusing on core functions and algorithms, with new functionalities requiring clinical trials [8]
北京健康产业营收突破万亿大关,创新医疗器械数量领跑全国